Connors, Joseph M.Jurczak, WojciechStraus, David J.Ansell, Stephen M.Kim, Won SeogGallamini, AndreaYounes, AnasAlekseev, SergeyIllés, ÁrpádPicardi, MarcoLech-Maranda, EwaOki, YasuhiroFeldman, TatyanaSmolewski, PiotrSavage, Kerry J.Bartlett, Nancy L.Walewski, JanChen, RobertRamchandren, RadhakrishnanZinzani, Pier LuigiCunningham, DavidRosta, AndrásJosephson, Neil C.Song, EricSachs, JessicaLiu, RachaelJolin, Hina A.Huebner, DirkRadford, John2019-02-252019-02-252018New England Journal of Medicine. -378 : 9 (2018), p. 331-344. -N. Engl. J. Med. - 0028-47930028-4793http://hdl.handle.net/2437/264057Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphomafolyóiratcikkopen access journalhttp://webpac.lib.unideb.hu:8082/ebib/CorvinaWeb?action=cclfind&resultview=long&ccltext=idno+BIBFORM077367OrvostudományokKlinikai orvostudományokhttp://www.nejm.org/doi/10.1056/NEJMoa1708984Massachusetts Medical Societyhttp://dx.doi.org/10.1056/NEJMoa170898462019-03-1500042323340000685041389324